CD9 and breast carcinoma: Alternatively, as a prototype of pan‐EV capture, a mixture of biotinylated antibodies against human CD9 and CD81 were used to immobilise EVs from SKBR3 breast carcinoma cells onto a black streptavidin‐coated 96‐well plate.